Acute Effects of Physical Exercise of Different Intensities on Biological and Psychological Outcomes Under Subclinical Stress and in Health

Brief Summary

Detailed Description

This study initially set out to include 43 adult (20 - 40 years) participants experiencing stress-related symptoms and 43 healthy controls, matched by age, sex, and fitness. These procedures were approved by the Swedish Ethical Review Autority (Approval number 2022-07297-01 and 2023-08181-02). Due to recruitment difficulties the design was later changed to include all individuals with sub-clinical stress symptoms and using stress as a covariate instead of comparing groups of healthy and stressed individuals (Ethical review approval number 2025-01786-02). This is a randomized-order crossover experimental trial with three experimental conditions separated by a wash-out period of 7 days: 20-min leg cycling exercise at moderate intensity, 20-min leg cycling exercise at vigorous intensity, and 20-min seated rest (passive control condition). Prior to entering the study, study inclusion/exclusion criteria will be controlled using digital screening. Before the experimental sessions, all participants will complete two introductory study visits. At the first introductory visit, the participant's maximal oxygen uptake (VO2max) will be determined using a fitness test. This information will be used to determine the individual workloads (% of individual VO2max) that the participant will be cycling at during the experimental session. At the second introductory visit, participants will complete a familiarization session, in which key methodological aspects of the study will be introduced to participants. Participants' augmentation index, as a measure of arterial stiffness, will also be completed during this visit. In each of the three experimental sessions, participants will perform a computerized working memory task (n-back task) pre- and post-exercise (or seated rest). During the working memory task, functional near-infrared spectroscopy (fNIRS) will be used to measure task-related changes in prefrontal cortex oxygenation. As such, each participant will complete six fNIRS measurements, two measurements (pre, post) for each of the three experimental sessions (moderate, high, control). Simultaneous with the fNIRS measurements, blood flow velocity in the left and right middle cerebral artery will be assessed during the n-back tasks using Transcranial Doppler ultrasound. At each experimental session, blood will also be sampled from the antecubital vein at six time points: pre the first n-back task, pre and post the cycling exercise (or seated rest), pre and post the second n-back task, and post the final 10-min seated rest. Whole blood samples will be assessed for blood gases, acid-base status, electrolytes, hematocrit level, platelet count, and glucose. The separated blood plasma and serum samples will be used for measurements of neurotrophic factors, lactate, biomarkers of stress and inflammation, and factors involved in blood glucose control. Blood samples will also be used for targeted DNA screening for alleles of the BDNF. Additionally, the participant's current mood, mental and physical fatigue, heart rate variability (HRV) and blood pressure will be assessed during four 10-min seated rest periods: pre and post n-back, and pre and post cycling exercise (or seated rest). Prior to each experimental study session, participants will have assessments of sleep quality the night before, current health status, physical activity level during the week prior to the test day, sleepiness level the last 10 min, and current mood. Participant's sleep quality and heart rate variability during the night before and after each experimental session will also be assessed. A release of an updated version of this study was attempted prior to completion of the study on October 3 2025, but due to a shutdown of the US goverment this was not possible to register until in November 24 2025.

Primary Outcomes

Secondary Outcomes

• DNA allele of brain-derived neurotrophic factor(At one time point at baseline)
• Cortisol(At three time points before and four time points after 20 minutes of exercise or seated rest (In total over 2 hours))
• Mental fatigue(At two time points before and two time points after 20 minutes of exercise or seated rest (In total over 2 hours))
• Sleep quality(Over the night before and the night after each experimental session (In total over 36 hours))
• Heart rate variability(Over the night before and the night after each experimental session (In total over 36 hours))
• Brain-derived neurotrophic factor(At three time points before and four time points after 20 minutes of exercise or seated rest (In total over 2 hours))
• Epinephrine(At three time points before and four time points after 20 minutes of exercise or seated rest (In total over 2 hours))
• Norepinephrine(At three time points before and four time points after 20 minutes of exercise or seated rest (In total over 2 hours))
• Mood(At two time points before and two time points after 20 minutes of exercise or seated rest (In total over 2 hours))
• Augmentation index(At a single time point at baseline)
• Working memory performance(At one time point before and one time point after 20 minutes of exercise or seated rest (In total over 1 hour))
• Physical fatigue(At two time points before and two time points after 20 minutes of exercise or seated rest (In total over 2 hours))
• Interleukin 6 (IL-6)(At three time points before and four time points after 20 minutes of exercise or seated rest (In total over 2 hours))
• Tumor necrosis factor alpha (TNF-α)(At three time points before and four time points after 20 minutes of exercise or seated rest (In total over 2 hours))
• Platelet count(At three time points before and four time points after 20 minutes of exercise or seated rest (In total over 2 hours))
• C-reactive protein (CRP)(At three time points before and four time points after 20 minutes of exercise or seated rest (In total over 2 hours))
• Sleepiness(At single time point before 20 minutes of exercise or seated rest)